BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv Y, Lin SY, Hu FF, Ye Z, Zhang Q, Wang Y, Guo AY. Landscape of cancer diagnostic biomarkers from specifically expressed genes. Brief Bioinform 2020;21:2175-84. [PMID: 31814027 DOI: 10.1093/bib/bbz131] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Yang L, Wang W, Rao X, Lai Y. Constructing a prognostic immune-related lncRNA model for colon cancer. Medicine 2022;101:e30447. [DOI: 10.1097/md.0000000000030447] [Reference Citation Analysis]
2 Gou Y, Fu Y, Li Y, Huang H, Tan W, Yuan Y, Ma J, Liu C, Wu H. Construction of a Novel kidney renal clear cell carcinoma microenvironment-related lncRNA pair Signature.. [DOI: 10.21203/rs.3.rs-1942003/v1] [Reference Citation Analysis]
3 Xie H, Shi M, Liu Y, Cheng C, Song L, Ding Z, Jin H, Cui X, Wang Y, Yao D, Wang P, Yao M, Zhang H. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma. Front Immunol 2022;13:914977. [DOI: 10.3389/fimmu.2022.914977] [Reference Citation Analysis]
4 Cao J, Xu Y, Liu X, Cai Y, Luo B. Innovative signature establishment using lymphangiogenesis-related lncRNA pairs to predict prognosis of hepatocellular carcinoma. Heliyon 2022;8:e10215. [PMID: 36033263 DOI: 10.1016/j.heliyon.2022.e10215] [Reference Citation Analysis]
5 Wu C, Liu F, Chen H, Liu Q, Song C, Cheng K, Gao Z, Fan C, Zhang Z. Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/7602482] [Reference Citation Analysis]
6 Xiao J, Wang X, Liu Y, Liu X, Yi J, Hu J. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Front Immunol 2022;13:881359. [DOI: 10.3389/fimmu.2022.881359] [Reference Citation Analysis]
7 Liu S, Peng X, Wu X, Bu F, Yu Z, Zhu J, Luo C, Zhang W, Liu J, Huang J. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02508-2] [Reference Citation Analysis]
8 Lino C, Barrias S, Chaves R, Adega F, Martins-lopes P, Fernandes J. Biosensors as diagnostic tools in clinical applications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188726] [Reference Citation Analysis]
9 Zhu Y, Shan D, Guo L, Chen S, Li X. Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma. IJGM 2022;Volume 15:1919-31. [DOI: 10.2147/ijgm.s343350] [Reference Citation Analysis]
10 Liu M, Chen H, Gao D, Ma C, Zhang Z, Manavalan B. Identification of Helicobacter pylori Membrane Proteins Using Sequence-Based Features. Computational and Mathematical Methods in Medicine 2022;2022:1-7. [DOI: 10.1155/2022/7493834] [Reference Citation Analysis]
11 Li Z, Wei J, Zheng H, Gan X, Song M, Zhang Y, Jin Y. Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients. Medicine (Baltimore) 2022;101:e28531. [PMID: 35029920 DOI: 10.1097/MD.0000000000028531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Deng M, Lin JB, Zhao RC, Li SH, Lin WP, Zou JW, Wei W, Guo RP. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma. BMC Cancer 2021;21:1347. [PMID: 34923955 DOI: 10.1186/s12885-021-09059-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang X, Chen K, Wang Z, Xu Y, Dai L, Bai T, Chen B, Yang W, Chen W. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer. Front Cell Dev Biol 2021;9:750709. [PMID: 34660608 DOI: 10.3389/fcell.2021.750709] [Reference Citation Analysis]
14 Sun JX, Xia QD, Liu CQ, Xu JZ, Xun Y, Lu JL, Hu J, Wang SG. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma. Dis Markers 2021;2021:8800358. [PMID: 34512816 DOI: 10.1155/2021/8800358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Han Z, Feng W, Hu R, Ge Q, Ma W, Zhang W, Xu S, Zhan B, Zhang L, Sun X, Zhou X. RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma. Sci Rep 2021;11:17797. [PMID: 34493740 DOI: 10.1038/s41598-021-96952-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Sun M, Zhang T, Wang Y, Huang W, Xia L. A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer. Front Genet 2021;12:695130. [PMID: 34434220 DOI: 10.3389/fgene.2021.695130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Chen H, Shen W, Ni S, Sang M, Wu S, Mu Y, Liu K, Li N, Zhu L, Xu G. Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD. Aging (Albany NY) 2021;13:20684-97. [PMID: 34438369 DOI: 10.18632/aging.203455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
18 Qi X, Chen G, Chen Z, Li J, Chen W, Lin J, Lin L. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature. Int J Gen Med 2021;14:4279-89. [PMID: 34421308 DOI: 10.2147/IJGM.S325240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shen S, Chen X, Hu X, Huo J, Luo L, Zhou X. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA. Cancer Med 2021. [PMID: 34378851 DOI: 10.1002/cam4.4189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Liu J, Wu H, Gao Z, Lou M, Yuan K. Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients. Bioengineered 2021;12:4123-35. [PMID: 34288805 DOI: 10.1080/21655979.2021.1953215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yin J, Li X, Lv C, He X, Luo X, Li S, Hu W. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma. Front Mol Biosci 2021;8:689224. [PMID: 34327215 DOI: 10.3389/fmolb.2021.689224] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
22 Zhao F, Wang M, Zhu J. Hypoxia-related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD-L1 squamous and adenocarcinoma NSCLC. Cancer Med 2021. [PMID: 34250747 DOI: 10.1002/cam4.4126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zhang Q, Wang Z, Yu X, Zhang M, Zheng Q, He Y, Guo W. Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer. Front Cell Dev Biol 2021;9:698296. [PMID: 34307375 DOI: 10.3389/fcell.2021.698296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 Ping S, Wang S, He J, Chen J. Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma. Pharmgenomics Pers Med 2021;14:667-81. [PMID: 34113151 DOI: 10.2147/PGPM.S310299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Hu H, Zhang Q, Hu FF, Liu CJ, Guo AY. A comprehensive survey for human transcription factors on expression, regulation, interaction, phenotype and cancer survival. Brief Bioinform 2021:bbab002. [PMID: 33517372 DOI: 10.1093/bib/bbab002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Hong W, Liang L, Gu Y, Qi Z, Qiu H, Yang X, Zeng W, Ma L, Xie J. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma. Mol Ther Nucleic Acids 2020;22:937-47. [PMID: 33251044 DOI: 10.1016/j.omtn.2020.10.002] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 55.5] [Reference Citation Analysis]
27 Muthu M, Chun S, Gopal J, Park GS, Nile A, Shin J, Shin J, Kim TH, Oh JW. The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy? Int J Mol Sci 2020;21:E5583. [PMID: 32759789 DOI: 10.3390/ijms21155583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Liu F, Pan Q, Wang L, Yi S, Liu P, Huang W. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma. BioFactors 2020;46:675-84. [DOI: 10.1002/biof.1639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]